Cargando…
Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2
Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer cases, and for the most cancer-related deaths. The survival pathway of Akt, its downstream effectors, the mammalian target of rapamycin (mTOR) and ribosomal protein S6 kinase (p70 S6K), and the Ras-extracellular signal-regulated...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447956/ https://www.ncbi.nlm.nih.gov/pubmed/28481292 http://dx.doi.org/10.3390/cancers9050046 |
_version_ | 1783239467519180800 |
---|---|
author | Kurgan, Nigel Tsakiridis, Evelyn Kouvelioti, Rozalia Moore, Jessy Klentrou, Panagiota Tsiani, Evangelia |
author_facet | Kurgan, Nigel Tsakiridis, Evelyn Kouvelioti, Rozalia Moore, Jessy Klentrou, Panagiota Tsiani, Evangelia |
author_sort | Kurgan, Nigel |
collection | PubMed |
description | Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer cases, and for the most cancer-related deaths. The survival pathway of Akt, its downstream effectors, the mammalian target of rapamycin (mTOR) and ribosomal protein S6 kinase (p70 S6K), and the Ras-extracellular signal-regulated kinase (Erk1/2) pathways are activated in cancer leading to cell survival and growth. Thus, approaches that inhibit these signaling molecules may prove useful in the fight against lung cancer. Exercise is associated with health benefits and a limited number of studies indicate that serum from physically active individuals inhibit mammary and prostate cancer cell growth. In this study, we examined the effects of post exercise serum on proliferation, survival, and signaling cascades of human NSCLC cells. Blood was collected from male subjects prior to, 5 min, 1 h, and 24 h after a single bout of high intensity interval exercise on a cycle ergometer. Exposure of NSCLC cells to post exercise serum resulted in the inhibition of cell proliferation and survival, as well as significant reduction of phosphorylated/activated Akt, mTOR, p70 S6K, and Erk1/2 levels compared to cells treated with serum taken pre-exercise. Our data suggest that post exercise serum has anti-cancer properties in lung cancer and deserves further systematic investigation in animal models. |
format | Online Article Text |
id | pubmed-5447956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-54479562017-05-30 Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2 Kurgan, Nigel Tsakiridis, Evelyn Kouvelioti, Rozalia Moore, Jessy Klentrou, Panagiota Tsiani, Evangelia Cancers (Basel) Article Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer cases, and for the most cancer-related deaths. The survival pathway of Akt, its downstream effectors, the mammalian target of rapamycin (mTOR) and ribosomal protein S6 kinase (p70 S6K), and the Ras-extracellular signal-regulated kinase (Erk1/2) pathways are activated in cancer leading to cell survival and growth. Thus, approaches that inhibit these signaling molecules may prove useful in the fight against lung cancer. Exercise is associated with health benefits and a limited number of studies indicate that serum from physically active individuals inhibit mammary and prostate cancer cell growth. In this study, we examined the effects of post exercise serum on proliferation, survival, and signaling cascades of human NSCLC cells. Blood was collected from male subjects prior to, 5 min, 1 h, and 24 h after a single bout of high intensity interval exercise on a cycle ergometer. Exposure of NSCLC cells to post exercise serum resulted in the inhibition of cell proliferation and survival, as well as significant reduction of phosphorylated/activated Akt, mTOR, p70 S6K, and Erk1/2 levels compared to cells treated with serum taken pre-exercise. Our data suggest that post exercise serum has anti-cancer properties in lung cancer and deserves further systematic investigation in animal models. MDPI 2017-05-08 /pmc/articles/PMC5447956/ /pubmed/28481292 http://dx.doi.org/10.3390/cancers9050046 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kurgan, Nigel Tsakiridis, Evelyn Kouvelioti, Rozalia Moore, Jessy Klentrou, Panagiota Tsiani, Evangelia Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2 |
title | Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2 |
title_full | Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2 |
title_fullStr | Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2 |
title_full_unstemmed | Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2 |
title_short | Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2 |
title_sort | inhibition of human lung cancer cell proliferation and survival by post-exercise serum is associated with the inhibition of akt, mtor, p70 s6k, and erk1/2 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447956/ https://www.ncbi.nlm.nih.gov/pubmed/28481292 http://dx.doi.org/10.3390/cancers9050046 |
work_keys_str_mv | AT kurgannigel inhibitionofhumanlungcancercellproliferationandsurvivalbypostexerciseserumisassociatedwiththeinhibitionofaktmtorp70s6kanderk12 AT tsakiridisevelyn inhibitionofhumanlungcancercellproliferationandsurvivalbypostexerciseserumisassociatedwiththeinhibitionofaktmtorp70s6kanderk12 AT kouveliotirozalia inhibitionofhumanlungcancercellproliferationandsurvivalbypostexerciseserumisassociatedwiththeinhibitionofaktmtorp70s6kanderk12 AT moorejessy inhibitionofhumanlungcancercellproliferationandsurvivalbypostexerciseserumisassociatedwiththeinhibitionofaktmtorp70s6kanderk12 AT klentroupanagiota inhibitionofhumanlungcancercellproliferationandsurvivalbypostexerciseserumisassociatedwiththeinhibitionofaktmtorp70s6kanderk12 AT tsianievangelia inhibitionofhumanlungcancercellproliferationandsurvivalbypostexerciseserumisassociatedwiththeinhibitionofaktmtorp70s6kanderk12 |